Aptamer Sciences Inc (KOSDAQ:291650)
891.00
-1.00 (-0.11%)
At close: Jun 5, 2026
Aptamer Sciences Market Cap
Aptamer Sciences has a market cap or net worth of 52.07 billion as of June 8, 2026. Its market cap has increased by 54.36% in one year.
Market Cap
52.07B
Enterprise Value
42.60B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
891.00
Market Cap Chart
Since September 16, 2020, Aptamer Sciences's market cap has decreased from 234.93B to 52.07B, a decrease of -77.84%. That is a compound annual growth rate of -23.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 52.07B | 70.63% |
| Dec 30, 2025 | 30.51B | -4.74% |
| Dec 30, 2024 | 32.03B | -47.67% |
| Dec 28, 2023 | 61.21B | -17.60% |
| Dec 29, 2022 | 74.29B | -48.53% |
| Dec 30, 2021 | 144.35B | -36.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PanGen Biotech | 67.98B |
| EyeGene | 63.98B |
| Progen | 62.27B |
| IMGT Co.,Ltd. | 62.02B |
| Psomagen | 52.71B |
| Quratis | 51.41B |
| Shaperon | 50.40B |
| ADBiotech | 49.20B |